Sarepta Shares Update on ENVISION Clinical Trial and Ongoing Duchenne Research
Today, Sarepta Therapeutics shared an update through a community letter regarding its research and clinical development programs, including an important decision about the Phase 3 ENVISION clinical trial evaluating ELEVIDYS in non-ambulatory and late-ambulatory individuals…Learn More



